Article ; Online: Gynecomastia in a Patient Taking Meloxicam-A Case Report.
Journal of primary care & community health
2020 Volume 11, Page(s) 2150132720952622
Abstract: Gynecomastia is benign enlargement of glandular tissue in the male breast. It occurs due to an imbalance of estrogen and testosterone. It may be unilateral or bilateral. Physiologic gynecomastia commonly occurs in infants and during puberty and is self- ... ...
Abstract | Gynecomastia is benign enlargement of glandular tissue in the male breast. It occurs due to an imbalance of estrogen and testosterone. It may be unilateral or bilateral. Physiologic gynecomastia commonly occurs in infants and during puberty and is self-limited. Gynecomastia may affect up to 50% of adult men over age 50 years old and can be related to underlying medical illness or caused by certain medications. Known causative agents include anti-androgenic and estrogenic drugs. Probable agents include alcohol and anti-ulcer, psychoactive, and antiretroviral medications. Non-steroidal anti-inflammatory drugs (NSAIDs) are not commonly associated with the development of gynecomastia. This case presents an instance in which the NSAID, meloxicam, was the only identified variable in a patient who developed unilateral gynecomastia. His breast tenderness and abnormal exam resolved spontaneously within 4 weeks of cessation of meloxicam therapy. |
---|---|
MeSH term(s) | Gynecomastia/chemically induced ; Humans ; Male ; Meloxicam ; Middle Aged ; Testosterone |
Chemical Substances | Testosterone (3XMK78S47O) ; Meloxicam (VG2QF83CGL) |
Language | English |
Publishing date | 2020-09-18 |
Publishing country | United States |
Document type | Case Reports ; Journal Article |
ZDB-ID | 2550221-9 |
ISSN | 2150-1327 ; 2150-1319 |
ISSN (online) | 2150-1327 |
ISSN | 2150-1319 |
DOI | 10.1177/2150132720952622 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.